9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East (ICAD-ME)

9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle East (ICAD-ME) is organized by Medetarian Conferences Organizing (MCO) and will be held from Apr 18 - 20, 2025 at Khalifa University, Abu Dhabi, Abu Dhabi, United Arab Emirates.

Description:
This year’s conference promises to be an exceptional gathering, showcasing cutting-edge research, innovative therapies, and collaborative efforts in the field of neurodegenerative disorders.

Our diverse program features esteemed speakers, thought-provoking sessions, and opportunities for meaningful dialogue among experts and practitioners. We are excited to explore the latest advancements and share insights that will drive progress in the understanding and treatment of Alzheimer’s disease and related conditions.

We extend our heartfelt gratitude to each of you for your commitment to advancing the field and for your participation in what we anticipate will be a truly inspiring event. Together, let us continue to push the boundaries of knowledge and work towards a future where effective treatments and preventive measures are within reach.

Objectives:

• Advance Knowledge: Present and discuss the latest research findings, scientific advancements, and clinical insights related to Alzheimer’s disease and related disorders.
• Foster Collaboration: Facilitate networking and collaboration among researchers, clinicians, and industry professionals to promote joint research efforts and the sharing of best practices.
• Explore Innovations: Showcase emerging technologies, innovative treatments, and novel approaches in the diagnosis, treatment, and management of Alzheimer’s and related conditions.
• Enhance Clinical Practice: Provide healthcare professionals with up-to-date information and practical strategies for improving patient care and clinical outcomes.
• Promote Regional Research: Highlight and support research initiatives and clinical practices specific to the Middle East, addressing regional challenges and opportunities in the field.
• Engage Stakeholders: Involve a diverse range of stakeholders, including policymakers, healthcare providers, and patient advocates, to discuss and address public health strategies and policy issues related to dementia care.
• Educate and Train: Offer educational sessions and workshops to enhance the skills and knowledge of medical professionals, researchers, and students in the field of Alzheimer’s disease and related disorders.
• Raise Awareness: Increase public and professional awareness about Alzheimer’s disease and related disorders, their impact, and the importance of ongoing research and treatment development.
• Encourage Patient-Centric Approaches: Focus on the needs and perspectives of patients and their families to ensure that research and clinical practices are aligned with improving quality of life and patient outcomes.
• Foster Innovation and Investment: Encourage investment in Alzheimer’s research and development by showcasing successful case studies, innovations, and opportunities for collaboration with industry partners.